Pressure Biosciences Inc
(PBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 23,290 | 22,760 | 21,820 | 19,470 | 29,270 |
| Cost of Goods | 14,860 | 14,260 | 13,120 | 12,850 | 18,430 |
| Gross Profit | 8,430 | 8,500 | 8,700 | 6,610 | 10,830 |
| Operating Expenses | 10,290 | 10,260 | 9,310 | 10,860 | 12,140 |
| Operating Income | -1,000 | -1,500 | -490 | -3,390 | -870 |
| Interest Expense | 290 | 240 | 430 | 1,610 | 430 |
| Other Income | 10 | 30 | 50 | -1,460 | -10 |
| Pre-tax Income | -1,280 | -1,710 | -870 | -6,460 | -1,310 |
| Income Tax | 3 | 3 | 10 | 1,150 | -490 |
| Net Income Continuous | -1,289 | -1,713 | -886 | -4,314 | -814 |
| Net Income Discontinuous | 0 | 220 | 4,330 | -380 | 0 |
| Net Income | $-1,280 | $-1,480 | $3,440 | $-8,000 | $-810 |
| EPS Basic Total Ops | -5.71 | -6.61 | 16.52 | -43.84 | -5.11 |
| EPS Basic Continuous Ops | -5.68 | -7.72 | -4.26 | -23.70 | -5.23 |
| EPS Basic Discontinuous Ops | N/A | 0.99 | 20.82 | -2.09 | N/A |
| EPS Diluted Total Ops | -5.71 | -6.61 | 16.52 | -43.84 | -5.11 |
| EPS Diluted Continuous Ops | -5.68 | -7.72 | -4.26 | -23.70 | -5.23 |
| EPS Diluted Discontinuous Ops | N/A | 0.99 | 20.82 | -2.09 | N/A |
| EBITDA(a) | $240 | $-200 | $920 | $-1,790 | $700 |